Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment

Summary

To evaluate the safety of two doses of Z-360 with Gemcitabine administration for subjects with unresectable advanced pancreatic cancer in order to determine the optimal dosage for PhaseII study

Timeline

Start

2005-09

Primary completion

2007-12

Completion

—

Drugs

Indications